Association of connexin 37 gene polymorphisms with risk of coronary artery disease in northern Han Chinese

Cardiology

Volumn 110, Issue 4, 2008, Pages 260-265

  Han, Yaling ^a   Xi, Suya ^a   Zhang, Xiaolin ^a   Yan, Chenghui ^a   Yang, Yong ^a   Kang, Jian ^a  

^a SHENYANG NORTHERN HOSPITAL   (China)

Author keywords

Connexin 37; Coronary artery disease; GJA4 gene; Haplotype; Linkage disequilibrium; Polymorphism

Indexed keywords

CONNEXIN 37;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CONNEXINS; CORONARY ARTERY DISEASE; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK;

EID: 46349087533     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112410     Document Type: Article

References (23)

1. Lusis AJ: Atherosclerosis. Nature 2000;407:233-241.
2. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
3. Gerszten RE, Mach F, Sauty A, Rosenzweiq A, Luster AD: Chemokines, leukocytes, and atherosclerosis. J Lab Clin Med 2000;136:87-92.
4. Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, Matsushita T, Kaba R, Halliday D: Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech 2001;52:301-322.
5. Kwak BR, Mulhaupt F, Veillard N, Gros DB, Mach F: Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002;22:225-230.
6. Wong CW, Christen T, Kwak BR: Connexins in leucocytes: shuttling messages? Cardiovasc Res 2004;62:357-367.
7. Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, Foglia BF, Chanson M, Goodenough DA, Kwak BR: Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 2006;12:950-954.
8. Cai WJ, Koltai S, Kocsis E, Scholz D, Schaper W, Schaper J: Connexin 37, not Cx40 and Cx43, is induced in vascular smooth muscle cells during coronary arteriogenesis. J Mol Cell Cardiol 2001;33:957-967.
9. Looft-Wilson RC, Payne GW, Segal SS: Connexin expression and conducted vasodilation along arteriolar endothelium in mouse skeletal muscle. J Appl Physiol 2004;97:1152-1158.
10. Wong CW, Christen T, Foglia B: Eliminating connexin37 enhances atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;110:III38/39.
11. Boerma M, Forsberg L, Van Zeijl L, Morgenstern R, De Faire U, Lemne C, Erlinge D, Thulin T, Hong Y, Cotgreave IA: A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 1999;246:211-218.
12. Yeh HI, Chou Y, Liu HF, Chang SC, Tsai CH: Connexin37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol 2001;81:251-255.
13. Wong CW, Christen T, Pfenniger A, James RW, Kwak BR: Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclerosis 2006;3:1-7.
14. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yolota M: Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Eng J Med 2002;347:1916-1923.
15. Listi F, Candore G, Lio D, Russo M, Colonna-Romano G, Caruso M, Hoffmann E, Caruso C: Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol 2005;102:269-271.
16. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, Tajika T, Murohara T, Yolota M: Association of gene polymorphisms with coronary artery disease in low or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 2003;42:1429-1437.
17. Yamada Y, Ichihara S, Izawa H, Tanaka M, Yokota M: Genetic risk for coronary artery disease in individuals with or without type 2 diabetes. Mol Genet Metab 2004;81:282-290.
18. Horan PG, Allen AR, Patterson CC, Spence MS, McGlinchey PG, Mckeown PP: The connexin 37 gene polymorphism and coronary artery disease in Ireland. Heart 2006;92:395-396.
19. Collings A, Islam MS, Juonala M, Rontu R, Kahonen M, Hutri-Kahonen N, Laitinen T, Marniemi J, Viikari JS, Raitakari OT, Lehtimaki TJ: Associations between connexin37 gene polymorphism and markers of subclinical atherosclerosis: The Cardiovascular Risk in Young Finns study. Atherosclerosis 2006, E-pub ahead of print.
20. Shi YY, He L: SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-98.
21. Koh KK: Effects of estrogen on the vascular wall: vasomotor function and inflammation. Cardiovasc Res 2002;55:714-726.
22. Cooper CD, Solan JL, Dolejsi MK, Lampe PD: Analysis of connexin phosphorylation sites. Methods 2000;20:196-204.
23. Lampe PD, TenBroek EM, Burt JM, Kurata WE, Johnson RG, Lau AF: Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol 2000;149:1503-1512.